Advertisement

Huawei signs patent licensing deal with smartphone rival Oppo as it fights to make money amid ongoing US pressure

  • The Shenzhen-based telecoms giant and Oppo have agreed to a patent cross-licensing deal
  • Huawei founder Ren Zhengfei told the company’s IP team earlier this year to step up efforts to turn its vast pool of patents into revenue

Reading Time:2 minutes
Why you can trust SCMP
1
Huawei Technologies Co has inked a patent-licensing deal with smartphone rival Oppo. Photo: AFP
Iris Dengin Shenzhen

Huawei Technologies Co has agreed to license some of its smartphone technologies to an old rival, as it struggles to make money after its lucrative handset business was hit by US trade sanctions that have cut off its access to advanced chips.

Advertisement

The Shenzhen-based telecommunications giant and Oppo, one of China’s top smartphone brands, said on Friday that they had agreed to a “patent cross-licensing” deal covering technologies including 5G.

The deal comes as Huawei accelerates efforts to make money from its assets, including its patent pool, as the company's revenues and profit shrink mainly because of US pressure. The financial terms of the deal, which Huawei said is its largest cross-licensing agreement with a Chinese company, were not disclosed.

Alan Fan, head of Huawei’s intellectual property department, did not elaborate on the specific patents involved in the deal. The partnership is “a win-win deal” for both companies, as it demonstrates the recognition and respect for each other’s intellectual property (IP), Adler Feng, Oppo’s chief intellectual property officer, said in a statement.

Huawei has recently been working to expand its patent-licensing arrangements. The world’s largest telecoms equipment maker and formerly China’s biggest smartphone vendor, was added to Washington’s trade blacklist in 2019 and has attempted to diversify its revenue streams by moving into areas such as cars and enterprise services.
Advertisement
Huawei founder Ren Zhengfei told the company’s IP team to step up efforts to turn its vast pool of patents into revenue via “reasonable pricing” and “generate an appropriate return” on the company’s research and development investments, according to a company memo made public in April.
loading
Advertisement